Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Cash from Operations (2016 - 2025)

vTv Therapeutics (VTVT) has disclosed Cash from Operations for 12 consecutive years, with 9251000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations fell 91.73% to 9251000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 25255000.0 through Dec 2025, changed 0.21% year-over-year, with the annual reading at 25255000.0 for FY2025, 0.21% changed from the prior year.
  • Cash from Operations hit 9251000.0 in Q4 2025 for vTv Therapeutics, down from 5222000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 706000.0 in Q2 2022 to a low of 9251000.0 in Q4 2025.
  • Historically, Cash from Operations has averaged 5248650.0 across 5 years, with a median of 5260500.0 in 2021.
  • Biggest five-year swings in Cash from Operations: skyrocketed 117.66% in 2022 and later crashed 973.51% in 2023.
  • Year by year, Cash from Operations stood at 6417000.0 in 2021, then dropped by 7.22% to 6880000.0 in 2022, then soared by 57.65% to 2914000.0 in 2023, then tumbled by 65.58% to 4825000.0 in 2024, then tumbled by 91.73% to 9251000.0 in 2025.
  • Business Quant data shows Cash from Operations for VTVT at 9251000.0 in Q4 2025, 5222000.0 in Q3 2025, and 5095000.0 in Q2 2025.